No abstract available
Keywords:
ALK; Acquired resistance; HER2; Lung cancer; Trastuzumab.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
MeSH terms
-
Anaplastic Lymphoma Kinase / metabolism*
-
Carbazoles / therapeutic use*
-
Dose-Response Relationship, Drug
-
Drug Resistance, Neoplasm / drug effects*
-
Follow-Up Studies
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / metabolism
-
Maximum Tolerated Dose
-
Piperidines / therapeutic use*
-
Protein Kinase Inhibitors / therapeutic use*
-
Survival Analysis
-
Trastuzumab / therapeutic use*
Substances
-
Carbazoles
-
Piperidines
-
Protein Kinase Inhibitors
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
alectinib
-
Trastuzumab